An improved method for obtaining optically pure (S)‐(l‐p‐menthen‐8‐yl)amine (12) has led to expedient syntheses of two hypothetical biogenetic intermediates on the way to aistoteline (7), namely (S)‐(N)‐(l‐p‐menthen‐8‐yl)‐2‐(3‐indolyl)ethylamine (3) and (S)‐(N)‐(l‐p‐menthen‐8‐yl)‐2‐(3‐indolyl)ethylideneamine (4). The latter has been transformed into (−)‐hobartine (6) in 64% yield via a stereoselective biomimetic cyclization by treatment with HCOOH. This unambiguous synthesis establishes the hitherto unknown absolute configuration of (−)‐hobartin (6). Several model cyclization reactions of N‐substituted α‐(terpen‐8‐yl)imine derivatives yielding unsaturated 3azabicyclo [3.3.1]nonane compounds are described.
No takes yet. Share an insight, caveat, or question.
Darbre et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: